Paper
Sensory and pulmonary irritation with exposure to methyl isocyanate.
Published Feb 1, 1986 · J. Ferguson, M. Schaper, M. F. Stock
Toxicology and applied pharmacology
Q2 SJR score
81
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Methyl isocyanate is a potent sensory and pulmonary irritant, causing respiratory rate decreases in mice at concentrations between 0.5 and 7.6 ppm.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Propyl ether. II. Pulmonary irritation and anaesthesia.
Propyl ether causes pulmonary irritation and anaesthesia, with a threshold limit value of about 100 p.p.m., and no impurities in technical grade ether influenced the responses.
2009·18citations·G. Nielsen et al.·Acta pharmacologica et toxicologica
Acta pharmacologica et toxicologica
Pulmonary and sensory irritation of diphenylmethane-4,4'- and dicyclohexylmethane-4,4'-diisocyanate.
MDI and SMDI are primarily pulmonary irritants, with recommended TLV-TWAs for industry being no higher than 0.3 and 0.4 mg/m3, respectively.
1985·37citations·D. Weyel et al.·Toxicology and applied pharmacology
Toxicology and applied pharmacology
Sensory irritation, pulmonary irritation, and acute lethality of a polymeric isocyanate and sensory irritation of 2,6-toleune diisocyanate.
The DES-N polymeric isocyanate is primarily a pulmonary irritant, with a maximum concentration permitted in industry at 1 mg/m3 and a recommended exposure limit for 2,6-toluene diisocyanate at 0.04 mg/m3 (0.006 ppm).
1982·57citations·D. Weyel et al.·Toxicology and applied pharmacology
Toxicology and applied pharmacology
Comparison of some mono- and diisocyanates as sensory irritants.
Aromatic and aliphatic diisocyanates have comparable potency as sensory irritants, while aromatic monoisocyanates are slightly less potent and aliphatic monoisocyanates are the least potent.
1981·32citations·G. Sangha et al.·Toxicology and applied pharmacology
Toxicology and applied pharmacology
Sensory irritation by toluene diisocyanate in single and repeated exposures.
Toluene diisocyanate (TDI) is the most potent sensory irritant tested, with cumulative effects from repeated exposures at or above 0.023 ppm, suggesting a reduced Threshold Limit Value for industrial exposure.
1979·79citations·G. Sangha et al.·Toxicology and applied pharmacology
Toxicology and applied pharmacology
Citations
Adsorption of methyl isocyanate on M4 (M=Fe, Ni, and Cu) cluster-decorated graphene and vacancy graphene: a DFT-D2 study
Metal cluster-decorated graphene and vacancy graphene show enhanced methyl isocyanate adsorption, with high adsorption energy and large Hirshfeld charge transfer.
2020·13citations·Jogender et al.·Structural Chemistry
Structural Chemistry
Effect of age at exposure on chromosome abnormalities in MIC-exposed Bhopal population detected 30 years post-disaster.
Age-related increase in chromosomal abnormalities in blood-lymphocytes is observed in MIC-exposed survivors, with severe exposure causing higher abnormalities.
2018·4citations·B. Ganguly et al.·Mutation research
Mutation research
Spectrum of health condition in methyl isocyanate (MIC)-exposed survivors measured after 30 years of disaster
Methyl isocyanate (MIC) exposure has long-term health effects on survivors, with reproductive, ophthalmic, and respiratory effects being prevalent, but the incidence of health problems has declined.
2018·15citations·B. Ganguly et al.·Environmental Science and Pollution Research
Environmental Science and Pollution Research
Optimizing the use of methods and measurement endpoints in respiratory safety pharmacology.
Optimizing the use of methods and measurement endpoints in respiratory safety pharmacology studies can enhance understanding of drug-induced effects on respiratory function and help design more effective studies.
2014·8citations·D. Murphy·Journal of pharmacological and toxicological methods
Journal of pharmacological and toxicological methods
Respiratory safety pharmacology - current practice and future directions.
Current respiratory safety pharmacology practices focus on pulmonary ventilation, but other parameters and models are needed to assess drug-induced respiratory dysfunction in animal models.
2014·15citations·D. Murphy·Regulatory toxicology and pharmacology : RTP
Regulatory toxicology and pharmacology : RTP